The Tail of Polycystin-1 Pays the Kidney a Complement
|
|
- Marsha Dawson
- 6 years ago
- Views:
Transcription
1 Articles in PresS. Am J Physiol Renal Physiol (March 23, 2016). doi: /ajprenal The Tail of Polycystin-1 Pays the Kidney a Complement Michael J. Caplan Department of Cellular and Molecular Physiology Yale University School of Medicine P.O. Box New Haven, CT michael.caplan@yale.edu Tel: Running title: Polycystin 1 and complement factor B Copyright 2016 by the American Physiological Society.
2 For those interested in the relationship between cellular signaling pathways and pathophysiology, Autosomal Dominant Polycystic Kidney Disease (ADPKD) offers almost an embarrassment of riches. ADPKD is the most common potentially lethal genetic disease, affecting more than one in one thousand individuals (5). It is the leading genetic cause of end stage renal disease, and accounts for ~4% of the population of patients requiring renal replacement therapy. Mutations in two genes, PKD1 and PKD2 account for essentially all cases of ADPKD. Although these genes and their protein products, polycystin 1 (PC1) and polycystin 2 (PC2), have been studied extensively for the past two decades, we still do not really understand what they do and why their loss leads to renal cystic disease (1, 15). The more deeply the mechanisms responsible for ADPKD are investigated, the more complex becomes the web of signaling processes that radiate from the two polycystin proteins. A recent review does an excellent job of organizing and summarizing these pathways (4), and the space allotted to the present piece does permit even a cursory discussion of their diversity. It is worth noting, however, that a significant subset of these pathways, including the intriguing process described in the paper by Wu et al. in the current issue of AJP Renal, originate with the cleavage and release of the C terminal tail of PC1 (1, 9, 10, 16, 17). PC1 is a truly enormous membrane protein, composed of 4,302 amino acids that are predicted to span the bilayer 11 times. The extracellular N terminus is roughly 3,000 residues in length and, during the course of the protein s post-translational processing, it is liberated by an autocatalytic cleavage and remains non-covalently attached to membrane-associated fragment (1, 11). Other cleavages release portions of this membrane-associated fragment, some of which remain embedded in the membrane (18) while others are released into the cytosol as soluble proteins and are able to enter the nucleus (2, 9). While the enzymes responsible for these
3 cleavages and the physiological stimuli that initiate them have yet to be fully elucidated, it is clear that the resultant fragments that enter the nucleus can exert profound effects on transcriptional pathways. A fragment of ~30 kda contains a nuclear localization sequence (2). This cleavage product, which is referred to as the PC1-CTT, has been shown to act as an inhibitor of cell proliferation and apoptosis through its direct interactions with the TCF and CHOP transcription factors that are integral components of these processes (8, 10). A shorter fragment of ~17 kda lacks its own nuclear localization sequence but enters the nucleus in association with STAT6 and p100, where it can influence STAT6-mediated transcription activity (9). The larger PC1-CTT also appears to be able to exert complex influences on the activities of STAT1, 3 and 6 as part of the coordinated response to renal injury or other stimuli (16). These pathways are the subject of an excellent recent review (17). Both of these fragments appear to be produced, at least in part, in response to mechanical perturbations and to renal injury and their release may help to coordinate cellular responses to these stimuli (2, 17). The paper by Wu et al. in this issue of AJP Renal contributes fascinating new insights into both the physiological roles of PC1 cleavage fragments and the pathways that may be involved in the pathogenesis of ADPKD. Wu et al. report that the ~30 kda PC1-CTT C terminal fragment of polycystin-1 stimulates the expression of complement factor B (CFB) via a STAT1-dependent mechanism. This study connects the previous work suggesting that the C terminal tail of polycystin-1 can activate STAT transcription factors (9, 16) to earlier studies from the present authors and others (7, 13), which indicate that complement factor B is found at high levels in cyst fluid. In addition, recent results from human studies indicate that the levels of complement proteins, including CFB, are elevated in urinary extracellular vesicles from ADPKD patients and that the levels of at least some of these proteins correlate with total kidney volume (12). Wu et al.
4 suggest that complement factor B may act to recruit M2 macrophages, which have been suggested to contribute to cystogenesis (6, 14). The authors find that complement factor B levels are elevated in human cystic kidneys and in a rodent model. They find that transfection of cells with a cdna encoding STAT1 results in elevated complement factor B expression and that STAT1 binds to the complement factor B promoter. They find that expression of the PC1 C terminal tail is associated with elevation of complement factor B levels and this elevation is reduced by inhibiting STAT1 function as well as by inhibiting the NF-κB pathway. Additionally, they show that exposing a macrophage cell line to complement factor B is associated with increased expression of arginase, a M2 marker. Taken together, these intriguing observations suggest that, at least in some contexts, the cleaved C terminal tail of PC1 can be an active participate in processes that contribute to the pathogenesis of ADPKD. They further suggest that inhibiting the expression of CFB or the pathways that lead to its expression constitutes a potential target for therapeutic development in ADPKD. It is perhaps somewhat counter-intuitive that the PC1-CTT could be involved in ADPKD pathogenesis. After all, the PC1-CTT is a fragment of the PC1 protein encoded by the PKD1 gene, and mutations that eliminate or severely reduce functional PC1 expression are causative of ADPKD. Furthermore, the PC1-CTT has anti-proliferative and anti-apoptotic activities that might be thought of as anti-cystogenic (8, 10). How can we understand, therefore, that the C terminal portion of the PC1 protein could contribute to a disease that can also be caused by this protein s absence? This is a difficult question to answer, since we do not have a clear understanding of the physiological role of PC1 or of the nature of the processes that lead to cyst formation in the context of ADPKD. Interestingly, over-expression of the PC1-CTT in zebrafish embryos can induce the formation of pronephric duct cysts and immunoreactive protein
5 corresponding to the molecular weight of the PC1-CTT has been detected in ADPKD cyst cells (9, 16). It has been suggested that PC1 may participate in modulating the renal response to injury (3, 19), and that injury may stimulate the production of the PC1-CTT. Since injury repair is a complex and highly choreographed process, it is quite possible that both the absence of the PC1- CTT and excessive or aberrant PC1-CTT activity could lead to aberrant and ultimately pathogenic responses. Future research will be required to bring together all of the pathways that are impacted by the PC1-CTT and to understand this protein fragment s normal function and its pathogenic potential
6 Literature Cited 1. Chapin HC and Caplan MJ. The cell biology of polycystic kidney disease. J Cell Biol 191: , Chauvet V, Tian X, Husson H, Grimm DH, Wang T, Hiesberger T, Igarashi P, Bennett AM, Ibraghimov-Beskrovnaya O, Somlo S, and Caplan MJ. Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus. J Clin Invest 114: , Happe H, Leonhard WN, van der Wal A, van de Water B, Lantinga-van Leeuwen IS, Breuning MH, de Heer E, and Peters DJ. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Hum Mol Genet 18: , Harris PC and Torres VE. Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease. J Clin Invest 124: , Harris PC and Torres VE. Polycystic kidney disease. Annu Rev Med 60: , Karihaloo A, Koraishy F, Huen SC, Lee Y, Merrick D, Caplan MJ, Somlo S, and Cantley LG. Macrophages promote cyst growth in polycystic kidney disease. J Am Soc Nephrol 22: , Lai X, Bacallao RL, Blazer-Yost BL, Hong D, Mason SB, and Witzmann FA. Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients. Proteomics Clinical applications 2: , Lal M, Song X, Pluznick J, Di Giovanni V, Merrick D, Rosenblum N, Chauvet V, Gottardi C, Pei Y, and Caplan M. Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling. Hum Mol Genet 17: , Low SH, Vasanth S, Larson CH, Mukherjee S, Sharma N, Kinter MT, Kane ME, Obara T, and Weimbs T. Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease. Dev Cell 10: 57-69, Merrick D, Chapin H, Baggs JE, Yu Z, Somlo S, Sun Z, Hogenesch JB, and Caplan MJ. The gamma- Secretase Cleavage Product of Polycystin-1 Regulates TCF and CHOP-Mediated Transcriptional Activation through a p300-dependent Mechanism. Dev Cell 22: , Qian F, Boletta A, Bhunia AK, Xu H, Liu L, Ahrabi AK, Watnick TJ, Zhou F, and Germino GG. Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations. Proc Natl Acad Sci U S A 99: , Salih M, Demmers JA, Bezstarosti K, Leonhard WN, Losekoot M, van Kooten C, Gansevoort RT, Peters DJ, Zietse R, Hoorn EJ, and Consortium D. Proteomics of Urinary Vesicles Links Plakins and Complement to Polycystic Kidney Disease. J Am Soc Nephrol, Su Z, Wang X, Gao X, Liu Y, Pan C, Hu H, Beyer RP, Shi M, Zhou J, Zhang J, Serra AL, Wuthrich RP, and Mei C. Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease. Journal of internal medicine 276: , Swenson-Fields KI, Vivian CJ, Salah SM, Peda JD, Davis BM, van Rooijen N, Wallace DP, and Fields TA. Macrophages promote polycystic kidney disease progression. Kidney Int 83: , Takiar V and Caplan MJ. Polycystic kidney disease: Pathogenesis and potential therapies. Biochim Biophys Acta, Talbot JJ, Shillingford JM, Vasanth S, Doerr N, Mukherjee S, Kinter MT, Watnick T, and Weimbs T. Polycystin-1 regulates STAT activity by a dual mechanism. Proc Natl Acad Sci U S A 108: , 2011.
7 Weimbs T, Olsan EE, and Talbot JJ. Regulation of STATs by polycystin-1 and their role in polycystic kidney disease. Jak-Stat 2: e23650, Woodward OM, Li Y, Yu S, Greenwell P, Wodarczyk C, Boletta A, Guggino WB, and Qian F. Identification of a polycystin-1 cleavage product, P100, that regulates store operated Ca entry through interactions with STIM1. PLoS One 5: e12305, Zhou J, Ouyang X, Schoeb TR, Bolisetty S, Cui X, Mrug S, Yoder BK, Johnson MR, Szalai AJ, and Mrug M. Kidney injury accelerates cystogenesis via pathways modulated by heme oxygenase and complement. J Am Soc Nephrol 23: ,
Kidney Disease Research
Thomas Weimbs Assistant Professor, Department of Molecular, Cellular & Developmental Biology Kidney Disease Research The mtor pathway is regulated by polycystin 1, and its inhibition reverses renal cystogenesis
More informationPolycystic Kidney Disease:The Cyst-ematic Destruction of Renal Function
Eukaryon Volume 5 Celebrating Darwin's 100th Anniversary Article 26 3-25-2009 Polycystic Kidney Disease:The Cyst-ematic Destruction of Renal Function Sadaf Ahmad Ray Choi Quincy Roberts Ben Simpson Jennillee
More informationCellular pathophysiology of cystic kidney disease: insight into future therapies
Int. J. Dev. Biol. 43: 457-461 (1999) Cellular pathophysiology of cystic kidney desease 457 Cellular pathophysiology of cystic kidney disease: insight into future therapies ELLIS D. AVNER*, RICHARD P.
More informationPolycystin-1 Expression in Fetal, Adult and Autosomal Dominant Polycystic Kidney
J Korean Med Sci 2006; 21: 425-9 ISSN 1011-8934 Copyright The Korean Academy of Medical Sciences Polycystin-1 Expression in Fetal, Adult and Autosomal Dominant Polycystic Kidney The mutation of the PKD1
More informationProduct Datasheet. SERCA2 ATPase Antibody (IID8) NB Unit Size: 100uL. Store at -20C. Avoid freeze-thaw cycles.
Product Datasheet SERCA2 ATPase Antibody (IID8) NB300-529 Unit Size: 100uL Store at -20C. Avoid freeze-thaw cycles. Publications: 5 Protocols, Publications, Related Products, Reviews, Research Tools and
More informationMacrophages Promote Cyst Growth in Polycystic Kidney Disease
Macrophages Promote Cyst Growth in Polycystic Kidney Disease Anil Karihaloo,* Farrukh Koraishy,* Sarah C. Huen,* Yashang Lee,* David Merrick, Michael J. Caplan, Stefan Somlo, and Lloyd G. Cantley* Departments
More informationDouble inhibition of camp and mtor signalling may potentiate the reduction of cell growth in ADPKD cells
Clin Exp Nephrol (2017) 21:203 211 DOI 10.1007/s10157-016-1289-1 ORIGINAL ARTICLE Double inhibition of camp and mtor signalling may potentiate the reduction of cell growth in ADPKD cells Lucia de Stephanis
More informationThe Cleaved Cytoplasmic Tail of Polycystin-1 Regulates Src-Dependent STAT3 Activation
The Cleaved Cytoplasmic Tail of Polycystin-1 Regulates Src-Dependent STAT3 Activation Jeffrey J. Talbot,* Xuewen Song, Xiaofang Wang, Markus M. Rinschen, Nicholas Doerr,* Wells B. LaRiviere, Bernhard Schermer,
More informationTitle: The fate of bone marrow-derived cells carrying a polycystic kidney disease mutation in the genetically normal kidney
Author's response to reviews Title: The fate of bone marrow-derived cells carrying a polycystic kidney disease mutation in the genetically normal kidney Authors: Elizabeth Verghese (Elizabeth.Verghese@vu.edu.au)
More informationNew therapeutic prospects in autosoma dominant polycystic kidney disease
http://www.senefro.org 2008 Órgano Oficial de la Sociedad Española de Nefrología short reviews New therapeutic prospects in autosoma dominant polycystic kidney disease Roser Torra Enfermedades Renales
More informationAutosomal dominant polycystic kidney disease (AD-
A Pilot Clinical Study to Evaluate Changes in Urine Osmolality and Urine camp in Response to Acute and Chronic Water Loading in Autosomal Dominant Polycystic Kidney Disease Irina Barash,* Manish P. Ponda,*
More informationGenetic Mutations in Autosomal Dominant Polycystic Kidney Disease Type-1
Review imedpub Journals http://www.imedpub.com/ DOI: 10.21767/2472-5056.100074 Genetic Mutations in Autosomal Dominant Polycystic Kidney Disease Type-1 Chandra Sanwal *, Karim Nooruddin, Chirag Patel,
More informationStrategies to Inhibit Cyst Formation in ADPKD
CJASN epress. Published on April 23, 2008 as doi: 10.2215/CJN.05651207 Strategies to Inhibit Cyst Formation in ADPKD James P. Calvet Department of Biochemistry and Molecular Biology and the Kidney Institute,
More informationGenetic Diseases Of The Kidney READ ONLINE
Genetic Diseases Of The Kidney READ ONLINE Genetic Diseases of the Kidney offers expert insight into the role of genetic abnormalities in the pathogenesis of abnormal kidney function and kidney disease.
More informationNew Treatments for ADPKD how close are we?
New Treatments for ADPKD how close are we? Leicester General Hospital 28 Jan 2012 Professor Albert Ong a.ong@sheffield.ac.uk The cystic degeneration of the kidneys, once it reaches the point where it can
More informationMBios 401/501: Lecture 12.1 Signaling IV. Slide 1
MBios 401/501: Lecture 12.1 Signaling IV Slide 1 Pathways that require regulated proteolysis 1. Notch and Delta 2. Wnt/ b-catenin 3. Hedgehog 4. NFk-B Our last topic on cell signaling are pathways that
More informationResearch Introduction
Research Introduction 9.17.13 Altered metabolism in polycystic kidney disease Telomerase activity in polycystic kidney disease cells Autosomal dominant polycystic kidney disease ADPKD is the most common
More informationPolycystic kidney disease where gene dosage counts Michael R. Eccles* and Cherie A. Stayner
Published: 01 April 2014 2014 Faculty of 1000 Ltd Polycystic kidney disease where gene dosage counts Michael R. Eccles* and Cherie A. Stayner Address: Department of Pathology, Dunedin School of Medicine,
More informationTubulointerstitial Renal Disease. Anna Vinnikova, MD Division of Nephrology
Tubulointerstitial Renal Disease Anna Vinnikova, MD Division of Nephrology Part I: Cystic Renal Disease www.pathguy.com Simple cysts Simple cysts May be multiple Usually 1 5cm, may be bigger Translucent,
More informationCover Page. Author: Hassane, Sabrine Title: Renal cyst and aneurysm formation in polycystic kidney disease mouse models Issue Date:
Cover Page The handle http://hdl.handle.net/1887/18605 holds various files of this Leiden University dissertation. Author: Hassane, Sabrine Title: Renal cyst and aneurysm formation in polycystic kidney
More informationCystic Renal Disease, for USMLE Step One. Howard J. Sachs, MD
Cystic Renal Disease, for USMLE Step One Howard J. Sachs, MD www.12daysinmarch.com The Major Players Medullary Sponge Kidney (MSK) Polycystic Kidney Disease (PKD) Autosomal Recessive: Childhood Autosomal
More informationAutosomal Dominant Polycystic Kidney Disease. Dr. Sameena Iqbal Nephrologist CIUSSS West Island
Autosomal Dominant Polycystic Kidney Disease Dr. Sameena Iqbal Nephrologist CIUSSS West Island Disclosure Honorarium for Consulting on the Reprise trial from Otsuka Mayo clinic preceptorship for PKD with
More informationSignaling. Dr. Sujata Persad Katz Group Centre for Pharmacy & Health research
Signaling Dr. Sujata Persad 3-020 Katz Group Centre for Pharmacy & Health research E-mail:sujata.persad@ualberta.ca 1 Growth Factor Receptors and Other Signaling Pathways What we will cover today: How
More informationMolecular and cellular pathogenesis of autosomal dominant polycystic kidney disease ONLINE
Brazilian Journal of Medical and Biological Research Online Provisional Version ISSN 0100-879X This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full
More informationRenal injury is a third hit promoting rapid development of adult polycystic kidney disease
Renal injury is a third hit promoting rapid development of adult polycystic kidney disease Ayumi Takakura 1, Leah Contrino 1, Xiangzhi Zhou 2, Joseph V. Bonventre 1, Yanping Sun 2, Benjamin D. Humphreys
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AD Award Number: W81XWH- TITLE: PRINCIPAL INVESTIGATOR: CONTRACTING ORGANIZATION: REPORT DATE: Ju TYPE OF REPORT: PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012
More informationTriptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD
Nephrol Dial Transplant (2010) 1 of 8 doi: 10.1093/ndt/gfp777 NDT Advance Access published February 4, 2010 Original Article Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model
More information7.06 Cell Biology EXAM #3 April 24, 2003
7.06 Spring 2003 Exam 3 Name 1 of 8 7.06 Cell Biology EXAM #3 April 24, 2003 This is an open book exam, and you are allowed access to books and notes. Please write your answers to the questions in the
More informationShuma Hirashio 1,2, Shigehiro Doi 1 and Takao Masaki 1*
Hirashio et al. Renal Replacement Therapy (2018) 4:24 https://doi.org/10.1186/s41100-018-0164-9 CASE REPORT Open Access Magnetic resonance imaging is effective for evaluating the therapeutic effect of
More informationCalcium-Mediated Mechanisms of Cystic Expansion
Chapman University Chapman University Digital Commons Pharmacy Faculty Articles and Research School of Pharmacy 10-12-2011 Calcium-Mediated Mechanisms of Cystic Expansion Shakila Abdul-Majeed University
More informationIndividual Renal Function in Polycystic Kidney Disease
CLINICAL NUCLEAR MEDICINE Volume 26, Number 6, pp 518 524 2001, Lippincott Williams & Wilkins Individual Renal Function in Polycystic Kidney Disease A Follow-Up Study ANDREAS D. FOTOPOULOS, M.D.,* KOSTAS
More informationComplexity DNA. Genome RNA. Transcriptome. Protein. Proteome. Metabolites. Metabolome
DNA Genome Complexity RNA Transcriptome Systems Biology Linking all the components of a cell in a quantitative and temporal manner Protein Proteome Metabolites Metabolome Where are the functional elements?
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AD Award Number: W81XWH-10-1-0504 TITLE: A New Therapeutic Strategy for Autosomal Dominant Polycystic Kidney Disease: Activation of AMP Kinase by Metformin PRINCIPAL INVESTIGATOR: Michael Caplan CONTRACTING
More informationSUISSE ADPKD Cohort Treatment and Outcomes with Tolvaptan, first in class Vasopressin V2 Antagonist. Hirslanden, 22 March 2018 Stefan Russmann
SUISSE ADPKD Cohort Treatment and Outcomes with Tolvaptan, first in class Vasopressin V2 Antagonist Hirslanden, 22 March 2018 Stefan Russmann 4 th of July 2004 Database development with outcomes and safety
More informationIL-17 in health and disease. March 2014 PSO13-C051n
IL-17 in health and disease March 2014 PSO13-C051n Originally Researchers Suggested That IL-12 and IL-4 drove Th Cell Differentiation Naïve CD4 + T cell Question: Which of these cell types is responsible
More informationFamily History of Renal Disease Severity Predicts the Mutated Gene in ADPKD
Family History of Renal Disease Severity Predicts the Mutated Gene in ADPKD Moumita Barua,* Onur Cil,* Andrew D. Paterson, Kairon Wang,* Ning He,* Elizabeth Dicks, Patrick Parfrey, and York Pei* *Division
More informationHHS Public Access Author manuscript Am J Kidney Dis. Author manuscript; available in PMC 2017 July 05.
HHS Public Access Author manuscript Published in final edited form as: Am J Kidney Dis. 2017 March ; 69(3): 482 484. doi:10.1053/j.ajkd.2016.10.021. Performance of the Chronic Kidney Disease Epidemiology
More informationThe 2 nd International Forum on Polycystic and Rare Kidney Diseases Program Sep3 rd -5 th, Hefei City, China
08:00-24:00 Check in 18:00-19:00 Cocktail reception 19:00-19:30 Vasopressin V2 receptor antagonists in the treatment of polycystic kidney disease Vicente Torres 19:30-20:00 Navigating the publishing process
More informationLysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease
Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease Linda Xiaoyan Li,, Julien Sage, Xiaogang Li J Clin Invest. 2017;127(7):2751-2764. https://doi.org/10.1172/jci90921.
More informationMultiple Gastric Carcinomas Associated with Potter Type III Cystic Disease
590 This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the
More informationHepatitis B virus X gene in the development of hepatocellular carcinoma. Citation Hong Kong Medical Journal, 2011, v. 17 n. 6, suppl. 6, p.
Title Hepatitis B virus X gene in the development of hepatocellular carcinoma Author(s) Ma, NF; Lau, SH; Hu, L; Dong, SS; Guan, XY Citation Hong Kong Medical Journal, 2011, v. 17 n. 6, suppl. 6, p. 44-47
More informationPrag. Polycystic kidney disease: ARPKD & ADPKD. Max Christoph Liebau
Prag Polycystic kidney disease: ARPKD & ADPKD Max Christoph Liebau Department of Pediatrics and Center for Molecular Medicine, University Hospital of Cologne Glasgow, 06th of September 2017 Cystic kidney
More informationAutosomal dominant polycystic disease (ADPKD) (Online
Cellular Biology Ciliary Polycystin-2 Is a Mechanosensitive Calcium Channel Involved in Nitric Oxide Signaling Cascades Wissam A. AbouAlaiwi, Maki Takahashi, Blair R. Mell, Thomas J. Jones, Shobha Ratnam,
More informationPractice Exam 2 MCBII
1. Which feature is true for signal sequences and for stop transfer transmembrane domains (4 pts)? A. They are both 20 hydrophobic amino acids long. B. They are both found at the N-terminus of the protein.
More informationReviewers' comments: Reviewer #1 (Remarks to the Author):
Reviewers' comments: Reviewer #1 (Remarks to the Author): The manuscript by Wu et al describes critical role of RNA binding protein CUGBP1 in the development of TGF-beta-mediated liver fibrosis. The activation
More informationMuscular Dystrophy. Biol 405 Molecular Medicine
Muscular Dystrophy Biol 405 Molecular Medicine Duchenne muscular dystrophy Duchenne muscular dystrophy is a neuromuscular disease that occurs in ~ 1/3,500 male births. The disease causes developmental
More informationSTIM1 fl/fl Ksp-Cre Mouse has Impaired Renal Water Balance
Original Paper 2016 The Author(s). 2016 Published The Author(s) by S. Karger AG, Basel Published online: June 24, 24, 2016 2016 Published by S. Karger AG, Basel 172 Accepted: May 09, 2016 1421-9778/16/0391-0172$39.50/0
More informationBasic Immunology. Lecture 5 th and 6 th Recognition by MHC. Antigen presentation and MHC restriction
Basic Immunology Lecture 5 th and 6 th Recognition by MHC. Antigen presentation and MHC restriction Molecular structure of MHC, subclasses, genetics, functions. Antigen presentation and MHC restriction.
More informationDiscovery and Optimization of Inhibitors of STAT3 Activation for the Treatment of Squamous Cell Carcinoma of the Head and Neck
Discovery and ptimization of Inhibitors of STAT3 Activation for the Treatment of Squamous Cell Carcinoma of the Head and Neck Feng Zhang Wipf Group Research Topic Seminar 02-09-2013 1 Feng Zhang @ Wipf
More informationNephrology Dialysis Transplantation
Nephrol Dial Transplant (1996) 11: 258-262 Molecular Basis of Renal Disease (Section Editor: L. G. Fine) Nephrology Dialysis Transplantation Identification of a gene for autosomal dominant polycystic kidney
More informationCilia-localized LKB1 regulates chemokine signalling, macrophage recruitment and tissue homeostasis in the kidney
Cilia-localized LKB1 regulates chemokine signalling, macrophage recruitment and tissue homeostasis in the kidney Amandine Viau, Frank Bienaimé, Kamile Lukas, Abhijeet P. Todkar, Manuel Knoll, Toma A. Yakulov,
More informationHyperglycemia in the absence of cilia accelerates cystogenesis and induces renal damage
Am J Physiol Renal Physiol 309: F79 F87, 2015. First published April 22, 2015; doi:10.1152/ajprenal.00652.2014. Hyperglycemia in the absence of cilia accelerates cystogenesis and induces renal damage Kelli
More informationVariable Cyst Development in Autosomal Dominant Polycystic Kidney Disease: The Biologic Context
Variable Cyst Development in Autosomal Dominant Polycystic Kidney Disease: The Biologic Context Wouter N. Leonhard, Hester Happe, and Dorien J.M. Peters Department of Human Genetics, Leiden University
More informationNeoplasia 18 lecture 6. Dr Heyam Awad MD, FRCPath
Neoplasia 18 lecture 6 Dr Heyam Awad MD, FRCPath ILOS 1. understand the role of TGF beta, contact inhibition and APC in tumorigenesis. 2. implement the above knowledge in understanding histopathology reports.
More informationCell Quality Control. Peter Takizawa Department of Cell Biology
Cell Quality Control Peter Takizawa Department of Cell Biology Cellular quality control reduces production of defective proteins. Cells have many quality control systems to ensure that cell does not build
More informationG-Protein Signaling. Introduction to intracellular signaling. Dr. SARRAY Sameh, Ph.D
G-Protein Signaling Introduction to intracellular signaling Dr. SARRAY Sameh, Ph.D Cell signaling Cells communicate via extracellular signaling molecules (Hormones, growth factors and neurotransmitters
More informationNIH Public Access Author Manuscript Curr Opin Nephrol Hypertens. Author manuscript; available in PMC 2010 March 1.
NIH Public Access Author Manuscript Published in final edited form as: Curr Opin Nephrol Hypertens. 2009 March ; 18(2): 99. doi:10.1097/mnh.0b013e3283262ab0. Advances in the Pathogenesis and Treatment
More informationThe expansion of molecular genetics knowledge
doi: http://dx.doi.org/10.11606/issn.1679-9836.v95ispe2p10-21 Contributions of genetically-modified animal models to the understanding and intervention in autosomal dominant polycystic kidney disease:
More informationNeutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo
original article http://www.kidney-international.org & International Society of Nephrology Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo Feng
More informationMECHANISM AND MODE OF HORMONE ACTION. Some definitions. Receptor: Properties of receptors. PRESENTED BY MBUNKUR GLORY NKOSI.
MECHANISM AND MODE OF HORMONE ACTION. PRESENTED BY MBUNKUR GLORY NKOSI. OUTLINE. Introduction Some definitions Hormone secretion, transport, and clearance from the blood. Feedback control of hormone secretion.
More informationLecture 15. Signal Transduction Pathways - Introduction
Lecture 15 Signal Transduction Pathways - Introduction So far.. Regulation of mrna synthesis Regulation of rrna synthesis Regulation of trna & 5S rrna synthesis Regulation of gene expression by signals
More informationHST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007
MIT OpenCourseWare http://ocw.mit.edu HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms.
More informationCalcium channel inhibition accelerates polycystic kidney disease progression in the Cy/ þ rat
http://www.kidney-international.org & 2008 International Society of Nephrology see commentary on page 251 Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy/ þ rat S
More informationSupplemental Figure 1. Western blot analysis indicated that MIF was detected in the fractions of
Supplemental Figure Legends Supplemental Figure 1. Western blot analysis indicated that was detected in the fractions of plasma membrane and cytosol but not in nuclear fraction isolated from Pkd1 null
More informationMajor Histocompatibility Complex (MHC) and T Cell Receptors
Major Histocompatibility Complex (MHC) and T Cell Receptors Historical Background Genes in the MHC were first identified as being important genes in rejection of transplanted tissues Genes within the MHC
More informationLate progression of renal pathology and cyst enlargement is reduced by rapamycin in a mouse model of nephronophthisis
original article http://www.kidney-international.org & 29 International Society of Nephrology Late progression of renal pathology and cyst enlargement is reduced by rapamycin in a mouse model of nephronophthisis
More informationBIOL212 Biochemistry of Disease. Metabolic Disorders - Obesity
BIOL212 Biochemistry of Disease Metabolic Disorders - Obesity Obesity Approx. 23% of adults are obese in the U.K. The number of obese children has tripled in 20 years. 10% of six year olds are obese, rising
More informationModel of cyst formation in autosomal dominant polycystic liver disease
Model of cyst formation in autosomal dominant polycystic liver disease Manoe J. Janssen *, Joost P.H. Drenth * Corresponding author: Manoe J. Janssen Received: 26.10.2012 Accepted: 03.07.2013 Published:
More informationRe-Purposing Drugs for the Treatment of Polycystic Kidney Disease:
Re-Purposing Drugs for the Treatment of Polycystic Kidney Disease: Partnership with the Polycystic Kidney Disease Foundation PKD Models: pcy and jck Mice, PCK Rat PreClinOmics, Inc. 1 PKDF Goals The Accelerating
More informationCYSTIC DISEASES of THE KIDNEY. Dr. Nisreen Abu Shahin
CYSTIC DISEASES of THE KIDNEY Dr. Nisreen Abu Shahin 1 Types of cysts 1-Simple Cysts 2-Dialysis-associated acquired cysts 3-Autosomal Dominant (Adult) Polycystic Kidney Disease 4-Autosomal Recessive (Childhood)
More informationmicrorna Therapeutics Harnessing the power of micrornas to target multiple pathways of disease
microrna Therapeutics Harnessing the power of micrornas to target multiple pathways of disease January 2018 Safe Harbor Statement Statements contained in this presentation regarding matters that are not
More informationTITLE: The Role of Constitutively Active Prolactin Receptors in the Natural History of Breast Cancer
AD Award Number: W81XWH-06-1-0448 TITLE: The Role of Constitutively Active Prolactin Receptors in the Natural History of Breast Cancer PRINCIPAL INVESTIGATOR: Kuang-tzu Huang CONTRACTING ORGANIZATION:
More informationA mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease
Rapid Report Am J Physiol Renal Physiol 310: F726 F731, 2016. First published January 13, 2016; doi:10.1152/ajprenal.00551.2015. A mild reduction of food intake slows disease progression in an orthologous
More informationSupplementary Figures. T Cell Factor-1 initiates T helper 2 fate by inducing GATA-3 and repressing Interferon-γ
Supplementary Figures T Cell Factor-1 initiates T helper 2 fate by inducing GATA-3 and repressing Interferon-γ Qing Yu, Archna Sharma, Sun Young Oh, Hyung-Geun Moon, M. Zulfiquer Hossain, Theresa M. Salay,
More informationBiol403 MAP kinase signalling
Biol403 MAP kinase signalling The mitogen activated protein kinase (MAPK) pathway is a signalling cascade activated by a diverse range of effectors. The cascade regulates many cellular activities including
More informationRAS Genes. The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes.
۱ RAS Genes The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes. Oncogenic ras genes in human cells include H ras, N ras,
More informationMolecular Oncology, oncology parameters see each test
Molecular Oncology, oncology parameters see each test DPD deficiency Dihydropyrimidine dehydrogenase deficiency (DPD deficiency) is an autosomal recessive metabolic disorder in which there is absent or
More informationADPKD, what have the last 10 years taught us? Arlene B. Chapman MD Professor of Medicine Director, Section of Nephrology University of Chicago
2016 ADPKD, what have the last 10 years taught us? Arlene B. Chapman MD Professor of Medicine Director, Section of Nephrology University of Chicago 2016 Can we TRUMP the cysts? Disclosures Consultant for
More informationSirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease
Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease Xia Zhou,, Ellis D. Avner, Xiaogang Li J Clin Invest. 2013;123(7):3084-3098. https://doi.org/10.1172/jci64401.
More informationInhibitory Effects of Torin2 on Proximal Tubular Development of the Xenopus laevis Pronephric Kidney
John Carroll University Carroll Collected Senior Honors Projects Theses, Essays, and Senior Honors Projects Spring 2013 Inhibitory Effects of Torin2 on Proximal Tubular Development of the Xenopus laevis
More informationGenetics and Cancer Ch 20
Genetics and Cancer Ch 20 Cancer is genetic Hereditary cancers Predisposition genes Ex. some forms of colon cancer Sporadic cancers ~90% of cancers Descendants of cancerous cells all cancerous (clonal)
More informationLESSON 3.2 WORKBOOK. How do normal cells become cancer cells? Workbook Lesson 3.2
For a complete list of defined terms, see the Glossary. Transformation the process by which a cell acquires characteristics of a tumor cell. LESSON 3.2 WORKBOOK How do normal cells become cancer cells?
More informationAtrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
(Courtesy of Magda Stumpfova. Used with permission.) Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy M.D. Gomes, S.H. Lecker, R.T. Jagoe, A. Navon, and A.L. Goldberg PNAS,
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationCorrelation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients
1568 Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients LIYING GUO 1, YU ZHANG 2, WEI ZHANG 3 and DILIMINA YILAMU 1 1 Department of
More informationJournal Club. 03/04/2012 Lama Nazzal
Journal Club 03/04/2012 Lama Nazzal NOTCH and the kidneys Is an evolutionarily conserved cell cell communication mechanism. Is a regulator of cell specification, differentiation, and tissue patterning.
More informationThe Role of OFD1 in the Pathogenesis of Polycystic Kidney Disease
University of New Mexico UNM Digital Repository Biomedical Sciences ETDs Electronic Theses and Dissertations 5-2015 The Role of OFD1 in the Pathogenesis of Polycystic Kidney Disease Stephanie Jerman Follow
More informationProximal Tubule Proliferation Is Insufficient to Induce Rapid Cyst Formation after Cilia Disruption
Proximal Tubule Proliferation Is Insufficient to Induce Rapid Cyst Formation after Cilia Disruption Neeraj Sharma,* Erik B. Malarkey,* Nicolas F. Berbari,* Amber K. O Connor,* Gregory B. Vanden Heuvel,
More informationBio 401 Sp2014. Multiple Choice (Circle the letter corresponding to the correct answer)
MIDTERM EXAM KEY (60 pts) You should have 5 pages. Please put your name on every page. You will have 70 minutes to complete the exam. You may begin working as soon as you receive the exam. NOTE: the RED
More informationThe Major Histocompatibility Complex (MHC)
The Major Histocompatibility Complex (MHC) An introduction to adaptive immune system before we discuss MHC B cells The main cells of adaptive immune system are: -B cells -T cells B cells: Recognize antigens
More informationClinical Study Acute Kidney Injury in ADPKD Patients with Pneumonia
SAGE-Hindawi Access to Research International Nephrology Volume 2, Article ID 6794, 6 pages doi:.46/2/6794 Clinical Study Acute Kidney Injury in ADPKD Patients with Pneumonia Carlos Franco Palacios,, 2
More informationEffects of Second Messengers
Effects of Second Messengers Inositol trisphosphate Diacylglycerol Opens Calcium Channels Binding to IP 3 -gated Channel Cooperative binding Activates Protein Kinase C is required Phosphorylation of many
More informationCell Biology Lecture 9 Notes Basic Principles of cell signaling and GPCR system
Cell Biology Lecture 9 Notes Basic Principles of cell signaling and GPCR system Basic Elements of cell signaling: Signal or signaling molecule (ligand, first messenger) o Small molecules (epinephrine,
More informationFurinDB: A Database of 20-Residue Furin Cleavage Site Motifs, Substrates and Their Associated Drugs
Int. J. Mol. Sci. 2011, 12, 1060-1065; doi:10.3390/ijms12021060 OPEN ACCESS Technical Note International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms FurinDB: A Database of 20-Residue
More informationC-Phycocyanin (C-PC) is a n«sjfc&c- waefc-jduble phycobiliprotein. pigment isolated from Spirulina platensis. This water- soluble protein pigment is
' ^Summary C-Phycocyanin (C-PC) is a n«sjfc&c- waefc-jduble phycobiliprotein pigment isolated from Spirulina platensis. This water- soluble protein pigment is of greater importance because of its various
More informationPaternal exposure and effects on microrna and mrna expression in developing embryo. Department of Chemical and Radiation Nur Duale
Paternal exposure and effects on microrna and mrna expression in developing embryo Department of Chemical and Radiation Nur Duale Our research question Can paternal preconceptional exposure to environmental
More informationMacrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease Li Chen,, Jared J. Grantham, Xiaogang Li J Clin Invest. 2015;125(6):2399-2412. https://doi.org/10.1172/jci80467.
More informationData Sheet. Notch Pathway Reporter Kit Catalog # 60509
Data Sheet Notch Pathway Reporter Kit Catalog # 60509 6042 Cornerstone Court W, Ste B Background The Notch signaling pathway controls cell fate decisions in vertebrate and invertebrate tissues. NOTCH signaling
More informationScott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION
Scott Abrams, Ph.D. Professor of Oncology, x4375 scott.abrams@roswellpark.org Kuby Immunology SEVENTH EDITION CHAPTER 11 T-Cell Activation, Differentiation, and Memory Copyright 2013 by W. H. Freeman and
More informationCELLS. Cells. Basic unit of life (except virus)
Basic unit of life (except virus) CELLS Prokaryotic, w/o nucleus, bacteria Eukaryotic, w/ nucleus Various cell types specialized for particular function. Differentiation. Over 200 human cell types 56%
More information